Bayside Laboratories

Bayside Laboratories was paid $4.73M by Medicaid between Jan 2018 and Dec 2024, across 90 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 29% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in New York

Rank by total paid#31 of 116

Median peer was paid$618K

This provider vs. median7.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	59,151	$548K
2019	56,825	$505K
2020	41,997	$418K
2021	68,886	$1.22M
2022	70,807	$1.17M
2023	67,430	$499K
2024incomplete	61,141	$371K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	29%	24,465	18,493	$1.36M
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	9.8%	21,367	21,193	$465K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	9.3%	23,870	18,080	$442K
80050	General health panel	6.4%	11,451	11,429	$303K
83036	Hemoglobin; glycosylated (A1C)	4.0%	28,457	28,251	$190K
80053	Comprehensive metabolic panel	3.0%	25,050	24,822	$142K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	2.9%	8,353	8,237	$136K
80061	Lipid panel	2.8%	31,441	31,234	$135K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	2.8%	8,289	8,166	$134K
82607		2.8%	15,705	15,581	$132K
84443	Thyroid stimulating hormone (TSH)	2.4%	19,216	19,024	$112K
82746		1.9%	10,734	10,663	$90K

78 more codes

G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	1.6%	1,362	$77K
84153		1.6%	5,602	$74K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.5%	29,079	$69K
86703		1.4%	6,319	$65K
81001		1.4%	28,568	$64K
86803		1.3%	8,552	$61K
82728		1.2%	5,990	$55K
84439		1.1%	8,882	$51K
87340		<1%	6,346	$45K
86706		<1%	6,520	$40K
84480		<1%	8,266	$36K
82043		<1%	10,516	$32K
86708		<1%	4,356	$31K
86704		<1%	4,432	$30K
84436		<1%	7,546	$29K
86769		<1%	790	$28K
87088		<1%	3,389	$22K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	348	$21K
86762		<1%	2,013	$21K
84403		<1%	1,146	$20K
86592		<1%	8,109	$19K
86765		<1%	2,011	$18K
83540		<1%	4,965	$17K
83550		<1%	3,429	$13K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	624	$13K
84550		<1%	4,617	$13K
82652		<1%	515	$12K
86735		<1%	1,970	$11K
83655		<1%	1,143	$11K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	1,247	$10K
84154		<1%	580	$10K
86787		<1%	1,644	$9K
82570		<1%	3,321	$9K
83735		<1%	1,882	$6K
87070		<1%	875	$6K
85651		<1%	3,009	$4K
82465		<1%	2,014	$4K
86696		<1%	430	$4K
86160		<1%	253	$4K
86480		<1%	118	$4K
86141		<1%	427	$3K
87184		<1%	513	$3K
80048	Basic metabolic panel (calcium, ionized)	<1%	428	$2K
86430		<1%	531	$2K
85610		<1%	369	$940.64
85730		<1%	240	$933.16
84481		<1%	113	$762.43
83090		<1%	69	$721.23
86695		<1%	258	$717.94
86063		<1%	186	$641.70
84146		<1%	44	$538.77
84100		<1%	194	$528.10
86140		<1%	167	$413.50
87109		<1%	51	$412.14
86376		<1%	43	$399.78
86038		<1%	62	$348.66
86900		<1%	141	$337.59
83001		<1%	26	$332.02
85044		<1%	336	$323.94
86694		<1%	43	$312.01
86800		<1%	39	$306.76
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	14	$280.49
84703		<1%	190	$253.32
82550		<1%	82	$233.54
82533		<1%	25	$212.44
82627		<1%	13	$177.63
86901		<1%	68	$169.56
83002		<1%	14	$159.09
86235		<1%	14	$157.05
84702		<1%	14	$103.15
82977		<1%	37	$97.38
87350		<1%	13	$92.40
82274		<1%	17	$64.14
84478		<1%	17	$61.01
80306		<1%	13	$58.00
84134		<1%	12	$49.96
84479		<1%	171	$38.16
99080		0%	67	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPESTUN, MARGARITA (PRESIDENT)